Medical Updates : Study Demonstrates Accuracy of NASH Diagnosis

Medindia Health News

Medindia largest health website in india. // via fulltextrssfeed.com

Study Demonstrates Accuracy of NASH Diagnosis

Apr 28th 2013, 17:16

Study Demonstrates Accuracy of NASH Diagnosis | Medindia

SELECT CATEGORY Doctor Patient Hospital Healthcare Student Chemist / Pharmacist Allied healthcare professional Consumer

Full Registration Benefits -

Free Homepages for Doctors

Free Homepages for Hospitals

Free Homepages for Medical Conference

Free Homepages for NGO's

Personal Health Record Creation

Access to all Medical Slides

Access to all Jobs & Products Sale

by Bidita Debnath on April 28, 2013 at 10:41 PMResearch News

Print
Email
Share
Text

At the International Liver CongressTM 2013, a Chinese study presented has demonstrated the accuracy of a non-invasive test for non-alcoholic steatohepatitis (NASH) diagnosis.

Study Demonstrates Accuracy of NASH Diagnosis

Non Alcoholic Fatty Liver disease (NAFLD) comprises two groups of patients; one group withsimple steatosis which is relatively benign and one group with NASH which may progress to cirrhosis and hepatocellular carcinoma. Up to now the only means of distinguishing the two was to perform a liver biopsy. Phosphorus magnetic resonance spectroscopy (31P-MRS), which allows non-invasive in vivo assessment of hepatocellular metabolism, was proven to show potential to distinguish the type of NAFLD.
The accuracy of the imaging technique could improve clinical procedures and enhance patientexperience compared to the discomfort and risk of undergoing the 'gold standard' test (liver biopsy) currently used for diagnosing NAFLD. These results will now need to be prospectively confirmed in independent cohorts.
NASH is a more advanced form of NAFLD and its incidence and prevalence is rising. Although CT and ultrasound scans are potential diagnostic tools for NAFLD, currently only liver biopsy can confirm whether the simpler NAFLD is present or whether the more serious NASH has developed.
Using 31PMRS, the liver metabolite changes from 132 patients with biopsy-proven NAFLD were obtained and the diagnostic performance of 31P-MRS for NASH was determined.
31P-MRS shows distinct alterations in ATP and PDE levels which are concordant with putative mechanisms in the progression of NAFLD. 31P-MRS shows fair diagnostic accuracy for NAFLD compared with liver biopsy, and using certain thresholds can be considered a reliable diagnostic tool for NASH.

Source-Eurekalert

Do you like this Report?